Effects of <i>Carpio</i>Decoction on the Structure of Kidney in Rats with Adriamycin-Induced Nephrosis

The aim of this study was to observe the effects of Cyprinus carpio decoction on the expression of aquaporins in rats with adriamycin-induced nephropathy and to explore the therapeutic mechanism on nephrotic edema. Total of 50 Wistar rats were randomly divided into normal group, model group, fosinopril group, Cyprinus carpio decoction treated with high dose group and low dose group consisting of 10 rats respectively. Nephropathy models were established by injecting adriamycin through tail vein and treated with Cyprinus carpio decoction. Urinary protein excretions in 12 h, serum albumin, total serum protein, serum sodium and potassium were measured by biochemical assay. The pathological changes and the expression of AQP1, AQP2, AQP3 inrat kidneys were respectively detected by HE stain and immunohistochemiscal assay. The results indicated: 1) The urinary protein excretion in 12 h (proteinuria) increased significantly along the time longed modeling, while no significant increasing in Cyprinus carpio decoction treated group (F = 5.23 -?41.89, P Cyprinus carpio decoction treated group were higher than that in model group (F = 13.12 -?15.48, P Cyprinus carpio decoction treated group were higher than that in model group (F = 3.42 - 3.96, P Cyprinus carpio decoction with interventing groups reduced proliferation, less inflammatory cell infiltration;4) In model group, the expressions of AQP1-3 in the renal tubule and collecting duct cells increased significantly than those in normal group, and those in Cyprinus carpio decoction treated group decreased than those in model group (F = 3.97 -?6.19, P Cyprinus carpio decoction could reduced the urinary protein excretion and alleviate pathological lesion and edema with adriamycin-induced nephropathy by decreasing the expressions of AQPs in kidneys.

Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China

Although the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)Omicron variant has spread,data on the clinical characteristics of infected patients are limited.In this study,the demographic,clinical characteristics,and laboratory data of 310 SARS-CoV-2 Omicron variant patients treated at Haihe Hospital of Tianjin were collected and analyzed.Information on these patients was compared to 96 patients with the Delta variant of concern(VOC)and 326 patients with the Beta VOC during the previous coronavirus disease 2019(COVID-19)outbreak in Harbin.Of the 310 patients infected with the Omicron variant,the median age was 35 years.Most patients were clinically classified as mild(57.74%),and the most common symptoms were cough(48.71%),fever(39.35%),and sore throat(38.26%).The results for different vaccination groups in the Omicron group showed that the median of“SARS-CoV-2 specific IgG”after 2 or 3 doses of vaccination was higher than the unvaccinated group(all Ps<0.05).Older age was associated with a higher proportion of moderate cases and lower asymptomatic and mild cases based on clinical classifications.Compared to the Delta and Beta groups,the median age of the Omicron group was younger.The total number of asymptomatic patients and mild patients in the Omicron virus group was higher than the Delta and Beta groups(60.97%vs.54.17%vs.47.55%).This study presented the clinical characteristics of the first group of patients infected with the Omicron variant in Tianjin,China,and compared their clinical features with patients infected by the Delta and Beta variants,which would increase our understanding of the characteristics of SARS-CoV-2 Omicron variant.